Ticker: BIAF

Company Overview bioAffinity Technologies, Inc. (NASDAQ: BIAF) focuses on developing noninvasive diagnostic tests for early-stage lung cancer and other lung diseases. Their primary product, CyPath® Lung, utilizes advanced data analysis and flow cytometry to detect cancer cell populations. Recent ...